認知機能低下のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Cognitive Decline Market Insights, Forecast to 2028

• レポートコード：QY2207C3856 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の認知機能低下の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に認知機能低下の世界市場のxxx％を占める「コリンエステラーゼ阻害剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「軽度認知障害（MCI）」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の認知機能低下の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの認知機能低下市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの認知機能低下市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 認知機能低下のグローバル主要メーカーには、Stryker、Smith & Nephew、Hill-Rom Services Inc.、Paramount Bed Holdings Co., Ltd.、ArjoHuntleigh、Talley Group Limited、Drive DeVilbiss Healthcare Ltd (Sidhil Limited)、Apex Medical Corp.、Medtronic、PROMA REHA, s. r. o.、Linet spol. S R.O.、DARCO International、DeRoyal Industries、BSN Medical (Essity)、Mölnlycke Health Care、TrueKAST (Wound Kair Concepts)、Thuasne SAS、DJO Global、ORTHOSERVICE AG、Breg, Inc.、Advanced Orthopaedics、ALGEOS、Hollister Incorporated、ConvaTec Group plc、Coloplast A/S、Medline Industries Inc.、Invacare Corporationなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 認知機能低下市場は、種類と用途によって区分されます。世界の認知機能低下市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 コリンエステラーゼ阻害剤、NMDA受容体拮抗薬 【用途別セグメント】 軽度認知障害（MCI）、認知症 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 認知機能低下製品概要 - 種類別市場（コリンエステラーゼ阻害剤、NMDA受容体拮抗薬） - 用途別市場（軽度認知障害（MCI）、認知症） - 調査の目的 ・エグゼクティブサマリー - 世界の認知機能低下販売量予測2017-2028 - 世界の認知機能低下売上予測2017-2028 - 認知機能低下の地域別販売量 - 認知機能低下の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別認知機能低下販売量 - 主要メーカー別認知機能低下売上 - 主要メーカー別認知機能低下価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（コリンエステラーゼ阻害剤、NMDA受容体拮抗薬） - 認知機能低下の種類別販売量 - 認知機能低下の種類別売上 - 認知機能低下の種類別価格 ・用途別市場規模（軽度認知障害（MCI）、認知症） - 認知機能低下の用途別販売量 - 認知機能低下の用途別売上 - 認知機能低下の用途別価格 ・北米市場 - 北米の認知機能低下市場規模（種類別、用途別） - 主要国別の認知機能低下市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの認知機能低下市場規模（種類別、用途別） - 主要国別の認知機能低下市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の認知機能低下市場規模（種類別、用途別） - 主要国別の認知機能低下市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の認知機能低下市場規模（種類別、用途別） - 主要国別の認知機能低下市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの認知機能低下市場規模（種類別、用途別） - 主要国別の認知機能低下市場規模（トルコ、サウジアラビア） ・企業情報 Stryker、Smith & Nephew、Hill-Rom Services Inc.、Paramount Bed Holdings Co., Ltd.、ArjoHuntleigh、Talley Group Limited、Drive DeVilbiss Healthcare Ltd (Sidhil Limited)、Apex Medical Corp.、Medtronic、PROMA REHA, s. r. o.、Linet spol. S R.O.、DARCO International、DeRoyal Industries、BSN Medical (Essity)、Mölnlycke Health Care、TrueKAST (Wound Kair Concepts)、Thuasne SAS、DJO Global、ORTHOSERVICE AG、Breg, Inc.、Advanced Orthopaedics、ALGEOS、Hollister Incorporated、ConvaTec Group plc、Coloplast A/S、Medline Industries Inc.、Invacare Corporation ・産業チェーン及び販売チャネル分析 - 認知機能低下の産業チェーン分析 - 認知機能低下の原材料 - 認知機能低下の生産プロセス - 認知機能低下の販売及びマーケティング - 認知機能低下の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 認知機能低下の産業動向 - 認知機能低下のマーケットドライバー - 認知機能低下の課題 - 認知機能低下の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Cognitive Decline Market
The global Cognitive Decline market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, by Drug Therapy accounting for % of the Cognitive Decline global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Mild Cognitive Impairment (MCI) segment is altered to an % CAGR throughout this forecast period.
China Cognitive Decline market size is valued at US$ million in 2021, while the North America and Europe Cognitive Decline are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cognitive Decline landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cognitive Decline market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cognitive Decline market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cognitive Decline market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cognitive Decline market.
Global Cognitive Decline Scope and Market Size
Cognitive Decline market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cognitive Decline market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
by Drug Therapy
Cholinesterase Inhibitors
NMDA receptor antagonists
by Non-Invasive Stimulation Devices
Vagus Nerve Stimulators
Deep Brain Stimulators
Transcranial Magnetic Stimulators (TMSs)
Segment by Application
Mild Cognitive Impairment (MCI)
Dementia
By Company
Stryker
Smith & Nephew
Hill-Rom Services Inc.
Paramount Bed Holdings Co., Ltd.
ArjoHuntleigh
Talley Group Limited
Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
Apex Medical Corp.
Medtronic
PROMA REHA, s. r. o.
Linet spol. S R.O.
DARCO International
DeRoyal Industries
BSN Medical (Essity)
Mölnlycke Health Care
TrueKAST (Wound Kair Concepts)
Thuasne SAS
DJO Global
ORTHOSERVICE AG
Breg, Inc.
Advanced Orthopaedics
ALGEOS
Hollister Incorporated
ConvaTec Group plc
Coloplast A/S
Medline Industries Inc.
Invacare Corporation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cognitive Decline Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cholinesterase Inhibitors
1.2.3 NMDA receptor antagonists
1.3 Market by Application
1.3.1 Global Cognitive Decline Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Mild Cognitive Impairment (MCI)
1.3.3 Dementia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cognitive Decline Market Perspective (2017-2028)
2.2 Cognitive Decline Growth Trends by Region
2.2.1 Cognitive Decline Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cognitive Decline Historic Market Size by Region (2017-2022)
2.2.3 Cognitive Decline Forecasted Market Size by Region (2023-2028)
2.3 Cognitive Decline Market Dynamics
2.3.1 Cognitive Decline Industry Trends
2.3.2 Cognitive Decline Market Drivers
2.3.3 Cognitive Decline Market Challenges
2.3.4 Cognitive Decline Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cognitive Decline Players by Revenue
3.1.1 Global Top Cognitive Decline Players by Revenue (2017-2022)
3.1.2 Global Cognitive Decline Revenue Market Share by Players (2017-2022)
3.2 Global Cognitive Decline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cognitive Decline Revenue
3.4 Global Cognitive Decline Market Concentration Ratio
3.4.1 Global Cognitive Decline Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cognitive Decline Revenue in 2021
3.5 Cognitive Decline Key Players Head office and Area Served
3.6 Key Players Cognitive Decline Product Solution and Service
3.7 Date of Enter into Cognitive Decline Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cognitive Decline Breakdown Data by Type
4.1 Global Cognitive Decline Historic Market Size by Type (2017-2022)
4.2 Global Cognitive Decline Forecasted Market Size by Type (2023-2028)
5 Cognitive Decline Breakdown Data by Application
5.1 Global Cognitive Decline Historic Market Size by Application (2017-2022)
5.2 Global Cognitive Decline Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cognitive Decline Market Size (2017-2028)
6.2 North America Cognitive Decline Market Size by Type
6.2.1 North America Cognitive Decline Market Size by Type (2017-2022)
6.2.2 North America Cognitive Decline Market Size by Type (2023-2028)
6.2.3 North America Cognitive Decline Market Share by Type (2017-2028)
6.3 North America Cognitive Decline Market Size by Application
6.3.1 North America Cognitive Decline Market Size by Application (2017-2022)
6.3.2 North America Cognitive Decline Market Size by Application (2023-2028)
6.3.3 North America Cognitive Decline Market Share by Application (2017-2028)
6.4 North America Cognitive Decline Market Size by Country
6.4.1 North America Cognitive Decline Market Size by Country (2017-2022)
6.4.2 North America Cognitive Decline Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cognitive Decline Market Size (2017-2028)
7.2 Europe Cognitive Decline Market Size by Type
7.2.1 Europe Cognitive Decline Market Size by Type (2017-2022)
7.2.2 Europe Cognitive Decline Market Size by Type (2023-2028)
7.2.3 Europe Cognitive Decline Market Share by Type (2017-2028)
7.3 Europe Cognitive Decline Market Size by Application
7.3.1 Europe Cognitive Decline Market Size by Application (2017-2022)
7.3.2 Europe Cognitive Decline Market Size by Application (2023-2028)
7.3.3 Europe Cognitive Decline Market Share by Application (2017-2028)
7.4 Europe Cognitive Decline Market Size by Country
7.4.1 Europe Cognitive Decline Market Size by Country (2017-2022)
7.4.2 Europe Cognitive Decline Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cognitive Decline Market Size (2017-2028)
8.2 Asia-Pacific Cognitive Decline Market Size by Type
8.2.1 Asia-Pacific Cognitive Decline Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cognitive Decline Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cognitive Decline Market Share by Type (2017-2028)
8.3 Asia-Pacific Cognitive Decline Market Size by Application
8.3.1 Asia-Pacific Cognitive Decline Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cognitive Decline Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cognitive Decline Market Share by Application (2017-2028)
8.4 Asia-Pacific Cognitive Decline Market Size by Region
8.4.1 Asia-Pacific Cognitive Decline Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cognitive Decline Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cognitive Decline Market Size (2017-2028)
9.2 Latin America Cognitive Decline Market Size by Type
9.2.1 Latin America Cognitive Decline Market Size by Type (2017-2022)
9.2.2 Latin America Cognitive Decline Market Size by Type (2023-2028)
9.2.3 Latin America Cognitive Decline Market Share by Type (2017-2028)
9.3 Latin America Cognitive Decline Market Size by Application
9.3.1 Latin America Cognitive Decline Market Size by Application (2017-2022)
9.3.2 Latin America Cognitive Decline Market Size by Application (2023-2028)
9.3.3 Latin America Cognitive Decline Market Share by Application (2017-2028)
9.4 Latin America Cognitive Decline Market Size by Country
9.4.1 Latin America Cognitive Decline Market Size by Country (2017-2022)
9.4.2 Latin America Cognitive Decline Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cognitive Decline Market Size (2017-2028)
10.2 Middle East & Africa Cognitive Decline Market Size by Type
10.2.1 Middle East & Africa Cognitive Decline Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cognitive Decline Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cognitive Decline Market Share by Type (2017-2028)
10.3 Middle East & Africa Cognitive Decline Market Size by Application
10.3.1 Middle East & Africa Cognitive Decline Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cognitive Decline Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cognitive Decline Market Share by Application (2017-2028)
10.4 Middle East & Africa Cognitive Decline Market Size by Country
10.4.1 Middle East & Africa Cognitive Decline Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cognitive Decline Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker Cognitive Decline Introduction
11.1.4 Stryker Revenue in Cognitive Decline Business (2017-2022)
11.1.5 Stryker Recent Developments
11.2 Smith & Nephew
11.2.1 Smith & Nephew Company Details
11.2.2 Smith & Nephew Business Overview
11.2.3 Smith & Nephew Cognitive Decline Introduction
11.2.4 Smith & Nephew Revenue in Cognitive Decline Business (2017-2022)
11.2.5 Smith & Nephew Recent Developments
11.3 Hill-Rom Services Inc.
11.3.1 Hill-Rom Services Inc. Company Details
11.3.2 Hill-Rom Services Inc. Business Overview
11.3.3 Hill-Rom Services Inc. Cognitive Decline Introduction
11.3.4 Hill-Rom Services Inc. Revenue in Cognitive Decline Business (2017-2022)
11.3.5 Hill-Rom Services Inc. Recent Developments
11.4 Paramount Bed Holdings Co., Ltd.
11.4.1 Paramount Bed Holdings Co., Ltd. Company Details
11.4.2 Paramount Bed Holdings Co., Ltd. Business Overview
11.4.3 Paramount Bed Holdings Co., Ltd. Cognitive Decline Introduction
11.4.4 Paramount Bed Holdings Co., Ltd. Revenue in Cognitive Decline Business (2017-2022)
11.4.5 Paramount Bed Holdings Co., Ltd. Recent Developments
11.5 ArjoHuntleigh
11.5.1 ArjoHuntleigh Company Details
11.5.2 ArjoHuntleigh Business Overview
11.5.3 ArjoHuntleigh Cognitive Decline Introduction
11.5.4 ArjoHuntleigh Revenue in Cognitive Decline Business (2017-2022)
11.5.5 ArjoHuntleigh Recent Developments
11.6 Talley Group Limited
11.6.1 Talley Group Limited Company Details
11.6.2 Talley Group Limited Business Overview
11.6.3 Talley Group Limited Cognitive Decline Introduction
11.6.4 Talley Group Limited Revenue in Cognitive Decline Business (2017-2022)
11.6.5 Talley Group Limited Recent Developments
11.7 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
11.7.1 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Details
11.7.2 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview
11.7.3 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Introduction
11.7.4 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Revenue in Cognitive Decline Business (2017-2022)
11.7.5 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments
11.8 Apex Medical Corp.
11.8.1 Apex Medical Corp. Company Details
11.8.2 Apex Medical Corp. Business Overview
11.8.3 Apex Medical Corp. Cognitive Decline Introduction
11.8.4 Apex Medical Corp. Revenue in Cognitive Decline Business (2017-2022)
11.8.5 Apex Medical Corp. Recent Developments
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Cognitive Decline Introduction
11.9.4 Medtronic Revenue in Cognitive Decline Business (2017-2022)
11.9.5 Medtronic Recent Developments
11.10 PROMA REHA, s. r. o.
11.10.1 PROMA REHA, s. r. o. Company Details
11.10.2 PROMA REHA, s. r. o. Business Overview
11.10.3 PROMA REHA, s. r. o. Cognitive Decline Introduction
11.10.4 PROMA REHA, s. r. o. Revenue in Cognitive Decline Business (2017-2022)
11.10.5 PROMA REHA, s. r. o. Recent Developments
11.11 Linet spol. S R.O.
11.11.1 Linet spol. S R.O. Company Details
11.11.2 Linet spol. S R.O. Business Overview
11.11.3 Linet spol. S R.O. Cognitive Decline Introduction
11.11.4 Linet spol. S R.O. Revenue in Cognitive Decline Business (2017-2022)
11.11.5 Linet spol. S R.O. Recent Developments
11.12 DARCO International
11.12.1 DARCO International Company Details
11.12.2 DARCO International Business Overview
11.12.3 DARCO International Cognitive Decline Introduction
11.12.4 DARCO International Revenue in Cognitive Decline Business (2017-2022)
11.12.5 DARCO International Recent Developments
11.13 DeRoyal Industries
11.13.1 DeRoyal Industries Company Details
11.13.2 DeRoyal Industries Business Overview
11.13.3 DeRoyal Industries Cognitive Decline Introduction
11.13.4 DeRoyal Industries Revenue in Cognitive Decline Business (2017-2022)
11.13.5 DeRoyal Industries Recent Developments
11.14 BSN Medical (Essity)
11.14.1 BSN Medical (Essity) Company Details
11.14.2 BSN Medical (Essity) Business Overview
11.14.3 BSN Medical (Essity) Cognitive Decline Introduction
11.14.4 BSN Medical (Essity) Revenue in Cognitive Decline Business (2017-2022)
11.14.5 BSN Medical (Essity) Recent Developments
11.15 Mölnlycke Health Care
11.15.1 Mölnlycke Health Care Company Details
11.15.2 Mölnlycke Health Care Business Overview
11.15.3 Mölnlycke Health Care Cognitive Decline Introduction
11.15.4 Mölnlycke Health Care Revenue in Cognitive Decline Business (2017-2022)
11.15.5 Mölnlycke Health Care Recent Developments
11.16 TrueKAST (Wound Kair Concepts)
11.16.1 TrueKAST (Wound Kair Concepts) Company Details
11.16.2 TrueKAST (Wound Kair Concepts) Business Overview
11.16.3 TrueKAST (Wound Kair Concepts) Cognitive Decline Introduction
11.16.4 TrueKAST (Wound Kair Concepts) Revenue in Cognitive Decline Business (2017-2022)
11.16.5 TrueKAST (Wound Kair Concepts) Recent Developments
11.17 Thuasne SAS
11.17.1 Thuasne SAS Company Details
11.17.2 Thuasne SAS Business Overview
11.17.3 Thuasne SAS Cognitive Decline Introduction
11.17.4 Thuasne SAS Revenue in Cognitive Decline Business (2017-2022)
11.17.5 Thuasne SAS Recent Developments
11.18 DJO Global
11.18.1 DJO Global Company Details
11.18.2 DJO Global Business Overview
11.18.3 DJO Global Cognitive Decline Introduction
11.18.4 DJO Global Revenue in Cognitive Decline Business (2017-2022)
11.18.5 DJO Global Recent Developments
11.19 ORTHOSERVICE AG
11.19.1 ORTHOSERVICE AG Company Details
11.19.2 ORTHOSERVICE AG Business Overview
11.19.3 ORTHOSERVICE AG Cognitive Decline Introduction
11.19.4 ORTHOSERVICE AG Revenue in Cognitive Decline Business (2017-2022)
11.19.5 ORTHOSERVICE AG Recent Developments
11.20 Breg, Inc.
11.20.1 Breg, Inc. Company Details
11.20.2 Breg, Inc. Business Overview
11.20.3 Breg, Inc. Cognitive Decline Introduction
11.20.4 Breg, Inc. Revenue in Cognitive Decline Business (2017-2022)
11.20.5 Breg, Inc. Recent Developments
11.21 Advanced Orthopaedics
11.21.1 Advanced Orthopaedics Company Details
11.21.2 Advanced Orthopaedics Business Overview
11.21.3 Advanced Orthopaedics Cognitive Decline Introduction
11.21.4 Advanced Orthopaedics Revenue in Cognitive Decline Business (2017-2022)
11.21.5 Advanced Orthopaedics Recent Developments
11.22 ALGEOS
11.22.1 ALGEOS Company Details
11.22.2 ALGEOS Business Overview
11.22.3 ALGEOS Cognitive Decline Introduction
11.22.4 ALGEOS Revenue in Cognitive Decline Business (2017-2022)
11.22.5 ALGEOS Recent Developments
11.23 Hollister Incorporated
11.23.1 Hollister Incorporated Company Details
11.23.2 Hollister Incorporated Business Overview
11.23.3 Hollister Incorporated Cognitive Decline Introduction
11.23.4 Hollister Incorporated Revenue in Cognitive Decline Business (2017-2022)
11.23.5 Hollister Incorporated Recent Developments
11.24 ConvaTec Group plc
11.24.1 ConvaTec Group plc Company Details
11.24.2 ConvaTec Group plc Business Overview
11.24.3 ConvaTec Group plc Cognitive Decline Introduction
11.24.4 ConvaTec Group plc Revenue in Cognitive Decline Business (2017-2022)
11.24.5 ConvaTec Group plc Recent Developments
11.25 Coloplast A/S
11.25.1 Coloplast A/S Company Details
11.25.2 Coloplast A/S Business Overview
11.25.3 Coloplast A/S Cognitive Decline Introduction
11.25.4 Coloplast A/S Revenue in Cognitive Decline Business (2017-2022)
11.25.5 Coloplast A/S Recent Developments
11.26 Medline Industries Inc.
11.26.1 Medline Industries Inc. Company Details
11.26.2 Medline Industries Inc. Business Overview
11.26.3 Medline Industries Inc. Cognitive Decline Introduction
11.26.4 Medline Industries Inc. Revenue in Cognitive Decline Business (2017-2022)
11.26.5 Medline Industries Inc. Recent Developments
11.27 Invacare Corporation
11.27.1 Invacare Corporation Company Details
11.27.2 Invacare Corporation Business Overview
11.27.3 Invacare Corporation Cognitive Decline Introduction
11.27.4 Invacare Corporation Revenue in Cognitive Decline Business (2017-2022)
11.27.5 Invacare Corporation Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Cognitive Decline Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of NMDA receptor antagonists
Table 4. Global Cognitive Decline Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Cognitive Decline Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cognitive Decline Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cognitive Decline Market Share by Region (2017-2022)
Table 8. Global Cognitive Decline Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cognitive Decline Market Share by Region (2023-2028)
Table 10. Cognitive Decline Market Trends
Table 11. Cognitive Decline Market Drivers
Table 12. Cognitive Decline Market Challenges
Table 13. Cognitive Decline Market Restraints
Table 14. Global Cognitive Decline Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cognitive Decline Revenue Share by Players (2017-2022)
Table 16. Global Top Cognitive Decline by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognitive Decline as of 2021)
Table 17. Ranking of Global Top Cognitive Decline Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cognitive Decline Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cognitive Decline Product Solution and Service
Table 21. Date of Enter into Cognitive Decline Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cognitive Decline Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cognitive Decline Revenue Market Share by Type (2017-2022)
Table 25. Global Cognitive Decline Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cognitive Decline Revenue Market Share by Type (2023-2028)
Table 27. Global Cognitive Decline Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cognitive Decline Revenue Share by Application (2017-2022)
Table 29. Global Cognitive Decline Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cognitive Decline Revenue Share by Application (2023-2028)
Table 31. North America Cognitive Decline Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Cognitive Decline Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Cognitive Decline Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Cognitive Decline Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Cognitive Decline Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Cognitive Decline Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Cognitive Decline Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Cognitive Decline Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Cognitive Decline Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Cognitive Decline Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Cognitive Decline Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Cognitive Decline Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Cognitive Decline Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Cognitive Decline Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Cognitive Decline Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Cognitive Decline Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Cognitive Decline Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Cognitive Decline Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Cognitive Decline Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Cognitive Decline Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Cognitive Decline Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Cognitive Decline Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Cognitive Decline Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Cognitive Decline Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Cognitive Decline Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Cognitive Decline Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Cognitive Decline Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Cognitive Decline Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Cognitive Decline Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Cognitive Decline Market Size by Country (2023-2028) & (US$ Million)
Table 61. Stryker Company Details
Table 62. Stryker Business Overview
Table 63. Stryker Cognitive Decline Product
Table 64. Stryker Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 65. Stryker Recent Developments
Table 66. Smith & Nephew Company Details
Table 67. Smith & Nephew Business Overview
Table 68. Smith & Nephew Cognitive Decline Product
Table 69. Smith & Nephew Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 70. Smith & Nephew Recent Developments
Table 71. Hill-Rom Services Inc. Company Details
Table 72. Hill-Rom Services Inc. Business Overview
Table 73. Hill-Rom Services Inc. Cognitive Decline Product
Table 74. Hill-Rom Services Inc. Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 75. Hill-Rom Services Inc. Recent Developments
Table 76. Paramount Bed Holdings Co., Ltd. Company Details
Table 77. Paramount Bed Holdings Co., Ltd. Business Overview
Table 78. Paramount Bed Holdings Co., Ltd. Cognitive Decline Product
Table 79. Paramount Bed Holdings Co., Ltd. Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 80. Paramount Bed Holdings Co., Ltd. Recent Developments
Table 81. ArjoHuntleigh Company Details
Table 82. ArjoHuntleigh Business Overview
Table 83. ArjoHuntleigh Cognitive Decline Product
Table 84. ArjoHuntleigh Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 85. ArjoHuntleigh Recent Developments
Table 86. Talley Group Limited Company Details
Table 87. Talley Group Limited Business Overview
Table 88. Talley Group Limited Cognitive Decline Product
Table 89. Talley Group Limited Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 90. Talley Group Limited Recent Developments
Table 91. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Details
Table 92. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview
Table 93. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Product
Table 94. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 95. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments
Table 96. Apex Medical Corp. Company Details
Table 97. Apex Medical Corp. Business Overview
Table 98. Apex Medical Corp. Cognitive Decline Product
Table 99. Apex Medical Corp. Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 100. Apex Medical Corp. Recent Developments
Table 101. Medtronic Company Details
Table 102. Medtronic Business Overview
Table 103. Medtronic Cognitive Decline Product
Table 104. Medtronic Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 105. Medtronic Recent Developments
Table 106. PROMA REHA, s. r. o. Company Details
Table 107. PROMA REHA, s. r. o. Business Overview
Table 108. PROMA REHA, s. r. o. Cognitive Decline Product
Table 109. PROMA REHA, s. r. o. Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 110. PROMA REHA, s. r. o. Recent Developments
Table 111. Linet spol. S R.O. Company Details
Table 112. Linet spol. S R.O. Business Overview
Table 113. Linet spol. S R.O. Cognitive Decline Product
Table 114. Linet spol. S R.O. Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 115. Linet spol. S R.O. Recent Developments
Table 116. DARCO International Company Details
Table 117. DARCO International Business Overview
Table 118. DARCO International Cognitive Decline Product
Table 119. DARCO International Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 120. DARCO International Recent Developments
Table 121. DeRoyal Industries Company Details
Table 122. DeRoyal Industries Business Overview
Table 123. DeRoyal Industries Cognitive Decline Product
Table 124. DeRoyal Industries Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 125. DeRoyal Industries Recent Developments
Table 126. BSN Medical (Essity) Company Details
Table 127. BSN Medical (Essity) Business Overview
Table 128. BSN Medical (Essity) Cognitive Decline Product
Table 129. BSN Medical (Essity) Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 130. BSN Medical (Essity) Recent Developments
Table 131. Mölnlycke Health Care Company Details
Table 132. Mölnlycke Health Care Business Overview
Table 133. Mölnlycke Health Care Cognitive Decline Product
Table 134. Mölnlycke Health Care Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 135. Mölnlycke Health Care Recent Developments
Table 136. TrueKAST (Wound Kair Concepts) Company Details
Table 137. TrueKAST (Wound Kair Concepts) Business Overview
Table 138. TrueKAST (Wound Kair Concepts) Cognitive Decline Product
Table 139. TrueKAST (Wound Kair Concepts) Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 140. TrueKAST (Wound Kair Concepts) Recent Developments
Table 141. Thuasne SAS Company Details
Table 142. Thuasne SAS Business Overview
Table 143. Thuasne SAS Cognitive Decline Product
Table 144. Thuasne SAS Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 145. Thuasne SAS Recent Developments
Table 146. DJO Global Company Details
Table 147. DJO Global Business Overview
Table 148. DJO Global Cognitive Decline Product
Table 149. DJO Global Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 150. DJO Global Recent Developments
Table 151. ORTHOSERVICE AG Company Details
Table 152. ORTHOSERVICE AG Business Overview
Table 153. ORTHOSERVICE AG Cognitive Decline Product
Table 154. ORTHOSERVICE AG Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 155. ORTHOSERVICE AG Recent Developments
Table 156. Breg, Inc. Company Details
Table 157. Breg, Inc. Business Overview
Table 158. Breg, Inc. Cognitive Decline Product
Table 159. Breg, Inc. Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 160. Breg, Inc. Recent Developments
Table 161. Advanced Orthopaedics Company Details
Table 162. Advanced Orthopaedics Business Overview
Table 163. Advanced Orthopaedics Cognitive Decline Product
Table 164. Advanced Orthopaedics Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 165. Advanced Orthopaedics Recent Developments
Table 166. ALGEOS Company Details
Table 167. ALGEOS Business Overview
Table 168. ALGEOS Cognitive Decline Product
Table 169. ALGEOS Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 170. ALGEOS Recent Developments
Table 171. Hollister Incorporated Company Details
Table 172. Hollister Incorporated Business Overview
Table 173. Hollister Incorporated Cognitive Decline Product
Table 174. Hollister Incorporated Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 175. Hollister Incorporated Recent Developments
Table 176. ConvaTec Group plc Company Details
Table 177. ConvaTec Group plc Business Overview
Table 178. ConvaTec Group plc Cognitive Decline Product
Table 179. ConvaTec Group plc Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 180. ConvaTec Group plc Recent Developments
Table 181. Coloplast A/S Company Details
Table 182. Coloplast A/S Business Overview
Table 183. Coloplast A/S Cognitive Decline Product
Table 184. Coloplast A/S Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 185. Coloplast A/S Recent Developments
Table 186. Medline Industries Inc. Company Details
Table 187. Medline Industries Inc. Business Overview
Table 188. Medline Industries Inc. Cognitive Decline Product
Table 189. Medline Industries Inc. Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 190. Medline Industries Inc. Recent Developments
Table 191. Invacare Corporation Company Details
Table 192. Invacare Corporation Business Overview
Table 193. Invacare Corporation Cognitive Decline Product
Table 194. Invacare Corporation Revenue in Cognitive Decline Business (2017-2022) & (US$ Million)
Table 195. Invacare Corporation Recent Developments
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cognitive Decline Market Share by Type: 2021 VS 2028
Figure 2. Cholinesterase Inhibitors Features
Figure 3. NMDA receptor antagonists Features
Figure 4. Global Cognitive Decline Market Share by Application: 2021 VS 2028
Figure 5. Mild Cognitive Impairment (MCI) Case Studies
Figure 6. Dementia Case Studies
Figure 7. Cognitive Decline Report Years Considered
Figure 8. Global Cognitive Decline Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Cognitive Decline Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Cognitive Decline Market Share by Region: 2021 VS 2028
Figure 11. Global Cognitive Decline Market Share by Players in 2021
Figure 12. Global Top Cognitive Decline Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognitive Decline as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Cognitive Decline Revenue in 2021
Figure 14. North America Cognitive Decline Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Cognitive Decline Market Size Market Share by Type (2017-2028)
Figure 16. North America Cognitive Decline Market Size Market Share by Application (2017-2028)
Figure 17. North America Cognitive Decline Market Size Share by Country (2017-2028)
Figure 18. United States Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Cognitive Decline Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Cognitive Decline Market Size Market Share by Type (2017-2028)
Figure 22. Europe Cognitive Decline Market Size Market Share by Application (2017-2028)
Figure 23. Europe Cognitive Decline Market Size Share by Country (2017-2028)
Figure 24. Germany Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Cognitive Decline Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Cognitive Decline Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Cognitive Decline Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Cognitive Decline Market Size Share by Region (2017-2028)
Figure 34. China Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Cognitive Decline Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Cognitive Decline Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Cognitive Decline Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Cognitive Decline Market Size Share by Country (2017-2028)
Figure 44. Mexico Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Cognitive Decline Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Cognitive Decline Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Cognitive Decline Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Cognitive Decline Market Size Share by Country (2017-2028)
Figure 50. Turkey Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Cognitive Decline Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Stryker Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 54. Smith & Nephew Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 55. Hill-Rom Services Inc. Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 56. Paramount Bed Holdings Co., Ltd. Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 57. ArjoHuntleigh Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 58. Talley Group Limited Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 59. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 60. Apex Medical Corp. Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 61. Medtronic Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 62. PROMA REHA, s. r. o. Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 63. Linet spol. S R.O. Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 64. DARCO International Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 65. DeRoyal Industries Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 66. BSN Medical (Essity) Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 67. Mölnlycke Health Care Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 68. TrueKAST (Wound Kair Concepts) Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 69. Thuasne SAS Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 70. DJO Global Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 71. ORTHOSERVICE AG Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 72. Breg, Inc. Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 73. Advanced Orthopaedics Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 74. ALGEOS Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 75. Hollister Incorporated Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 76. ConvaTec Group plc Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 77. Coloplast A/S Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 78. Medline Industries Inc. Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 79. Invacare Corporation Revenue Growth Rate in Cognitive Decline Business (2017-2022)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

---